QuiVad
My list

Home / Sweden / Dicot Pharma AB

Dicot Pharma AB

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 3.46% on October 24, 2025. The shaded band matches the twelve months of the first chart.

August 20, 2024 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Dicot Pharma AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

53 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 7, 2026Citadel Securities (Europe) Limited0.55%
June 22, 2026Guevoura Fund0.66%
June 17, 2026Guevoura Fund1.10%
June 16, 2026Guevoura Fund1.02%
June 12, 2026Guevoura Fund0.92%
June 11, 2026Guevoura Fund0.87%
June 9, 2026Guevoura Fund0.66%
June 4, 2026Guevoura Fund0.51%
June 3, 2026Citadel Securities (Europe) Limited0.51%
June 1, 2026Quartys Limited0.79%
June 1, 2026Citadel Securities (Europe) Limited0.59%
May 11, 2026Brummer Multi-Strategy AB0.62%
March 27, 2026Brummer Multi-Strategy AB1.07%
March 26, 2026Brummer Multi-Strategy AB0.98%
March 18, 2026GSA Capital Partners LLP0.58%
March 13, 2026Brummer Multi-Strategy AB0.75%
March 12, 2026GSA Capital Partners LLP0.69%
March 9, 2026GSA Capital Partners LLP0.78%
March 4, 2026GSA Capital Partners LLP0.80%
February 24, 2026GSA Capital Partners LLP0.70%
February 16, 2026GSA Capital Partners LLP0.61%
February 6, 2026GSA Capital Partners LLP0.51%
January 30, 2026Brummer Multi-Strategy AB0.54%
January 29, 2026Brummer Multi-Strategy AB0.66%
January 28, 2026Brummer Multi-Strategy AB0.97%
December 30, 2025Brummer Multi-Strategy AB1.32%
November 19, 2025Citadel Securities (Europe) Limited0.53%
November 14, 2025Citadel Securities (Europe) Limited0.62%
November 13, 2025Citadel Securities (Europe) Limited0.57%
November 11, 2025Citadel Securities (Europe) Limited0.68%
November 10, 2025Citadel Securities (Europe) Limited0.59%
November 7, 2025Citadel Securities (Europe) Limited0.75%
November 4, 2025Citadel Securities (Europe) Limited0.84%
October 30, 2025Citadel Securities (Europe) Limited0.79%
October 29, 2025Citadel Securities (Europe) Limited0.56%
October 27, 2025Brummer Multi-Strategy AB1.14%
October 24, 2025Citadel Securities (Europe) Limited0.79%
October 23, 2025Brummer Multi-Strategy AB1.42%
September 2, 2025Brummer Multi-Strategy AB1.14%
August 27, 2025Brummer Multi-Strategy AB0.90%
August 26, 2025Brummer Multi-Strategy AB0.80%
September 10, 2024Guevoura Fund1.25%
September 6, 2024Guevoura Fund2.61%
September 5, 2024Guevoura Fund2.55%
September 4, 2024Guevoura Fund2.40%
September 3, 2024Guevoura Fund2.37%
September 2, 2024Guevoura Fund2.25%
August 30, 2024Guevoura Fund2.10%
August 27, 2024Guevoura Fund1.81%
August 26, 2024Guevoura Fund1.43%

Download 53 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Dicot Pharma AB, source Finansinspektionen, data as at July 7, 2026, https://www.quivad.com/action/dicot-pharma-ab